Evidence map›Paper›PMID 35896887›Full record

ArticleNetherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation2023

The Netherlands Heart Tissue Bank : Strengthening the cardiovascular research infrastructure with an open access Cardiac Tissue Repository.

M T H M Henkens, J F van Ast, A S J M Te Riele, A C Houweling, A S Amin, R Nijveldt, M L Antoni, X Li, S M T Wehrens, J H von der Thüsen and 8 more

Abstract read
In one paragraph

Article in Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. The Dutch cardiomyopathy registry (DCR); rationale and registry design.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2026
    Article
  2. Identification of disease-specific pathways and modifiers in phospholamban R14del cardiomyopathy: rationale, design and baseline characteristics of DECIPHER-PLN cohort.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2025
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

M T H M HenkensNetherlands Heart Institute (NLHI), Utrecht, The Netherlands. michiel.henkens@heart-institute.nl.ORCID http://orcid.org/0000-0001-6222-071X
J F van AstNetherlands Heart Institute (NLHI), Utrecht, The Netherlands.
A S J M Te RieleNetherlands Heart Institute (NLHI), Utrecht, The Netherlands.
A C HouwelingDepartment of Clinical Genetics, Amsterdam UMC (location VUmc), Amsterdam, The Netherlands.
A S AminDepartment of Clinical and Experimental Cardiology, Heart Failure Research Centre, Amsterdam UMC, Amsterdam, The Netherlands.
R NijveldtDepartment of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
M L AntoniDepartment of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands.
X LiDepartment of Pathology, CARIM, Maastricht University Medical Centre, Maastricht, The Netherlands.
S M T WehrensNetherlands Brain Bank, Netherlands Institute for Neuroscience, Amsterdam, The Netherlands.
J H von der ThüsenErasmus MC Transplant Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
K DammanDepartment of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
E N Ter HorstPLN Heart Foundation, Middenmeer, The Netherlands.
O C ManintveldDepartment of Cardiology, Erasmus Medical Centre, Rotterdam, The Netherlands.
R Y Abma-SchoutenDutch Heart Foundation, Den Haag, The Netherlands.
H W M NiessenDepartment of Pathology and Cardiac Surgery, Amsterdam UMC, location AMC and VUmc, ACS, Amsterdam, The Netherlands.
H H W SilljéDepartment of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
J W JukemaNetherlands Heart Institute (NLHI), Utrecht, The Netherlands.
P A DoevendansNetherlands Heart Institute (NLHI), Utrecht, The Netherlands.

Funding

Hartstichting 2018T097
6 · The paper itself

Abstract

aimCardiac diseases remain a leading cause of cardiovascular disease (CVD) related hospitalisation and mortality. That is why research to improve our understanding of pathophysiological processes underlying cardiac diseases is of great importance. There is a strong need for healthy and diseased human cardiac tissue and related clinical data to accomplish this, since currently used animal and in vitro disease models do not fully grasp the pathophysiological processes observed in humans. This design paper describes the initiative of the Netherlands Heart Tissue Bank (NHTB) that aims to boost CVD-related research by providing an open-access biobank.

methodsThe NHTB, founded in June 2020, is a non-profit biobank that collects and stores biomaterial (including but not limited to myocardial tissue and blood samples) and clinical data of individuals with and without previously known cardiac diseases. All individuals aged ≥ 18 years living in the Netherlands are eligible for inclusion as a potential future donor. The stored samples and clinical data will be available upon request for cardiovascular researchers.

conclusionTo improve the availability of cardiac tissue for cardiovascular research, the NHTB will include extensive (cardiac) biosamples, medical images, and clinical data of donors with and without a previously known cardiac disease. As such, the NHTB will function as a translational bridge to boost a wide range of cardiac disease-related fundamental and translational studies.

Indexed as

Biological specimen banksHeart diseasesRegistriesTissue banksTranslational research

Identifiers

PMID35896887
PMCPMC9807721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.